Figure 3.
![Figure 3. PFS in ATLL. (A-B) PFS in acute (A) and lymphomatous ATLL (B) cases according to first-line treatment (AI [AZT-IFN] vs chemotherapy alone). (C) PFS in 51 aggressive ATLL cases who achieved CR altogether (28 acute, 2 UC, and 21 lymphomatous). (D) PFS in 27 acute ATLL cases who achieved CR. Survival estimates were calculated by Kaplan-Meier method and compared using the log-rank test.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/2/6/10.1182_bloodadvances.2017011106/4/advances011106f3.jpeg?Expires=1724951158&Signature=T5ziic~KN02lsIektbpejxWzgaOX4UBfRS5JBhm1Tzx47vR7S3ZrwMRyQKtluYuadTxV4675su6UZ2KJSopZsPqj8WGMIJOM45DZkVUwi0D5rozs~t1tRRjTv5UKtw~ziIQX0q2lBvILhotS1PfgskOT-dUuzWhoA9PHSqnh9IZkpSg-YSHGD6GxKjOQA36TzZmS9HdWJl5DQFPYHperQLtoFtdYprZnVQaPjq0u0-52ENzr2Njl5WZJF~zi-lyYfNNgwZHPyJ472tm9tTv~mPxjnWm1j0rjiQACEMPAtPp3HU6-r2u4tfY1TW1QLkX3ZDv9hpZY2UirPWj7oQ42Pg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PFS in ATLL. (A-B) PFS in acute (A) and lymphomatous ATLL (B) cases according to first-line treatment (AI [AZT-IFN] vs chemotherapy alone). (C) PFS in 51 aggressive ATLL cases who achieved CR altogether (28 acute, 2 UC, and 21 lymphomatous). (D) PFS in 27 acute ATLL cases who achieved CR. Survival estimates were calculated by Kaplan-Meier method and compared using the log-rank test.
